Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00727129 | Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms | PHASE3 | COMPLETED | 495 | — | — | Jul 1, 2004 | Aug 1, 2005 | Sep 26, 2008 | - | — |
| Name | Type | Description |
|---|---|---|
| Divigel | DRUG | - |
Inclusion Criteria: * Postmenopausal women * Have moderate to severe hot flashes * Normal Pap Smear Exclusion Criteria: * Abnormal mammogram * Abnormal clinical breast exam * BMI \>35